查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912771

医用多用途引流导管市场：按产品类型、材质、尺寸、应用、最终用户和销售管道划分 - 全球预测（2026-2032年）

Medical Multi-Use Drainage Catheters Market by Product Type, Material, Size, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用多用途引流导管市场价值将达到 7.7527 亿美元，到 2026 年将成长至 8.3689 亿美元，到 2032 年将达到 14.2027 亿美元，复合年增长率为 9.03%。

关键市场统计数据
基准年 2025 7.7527亿美元
预计年份：2026年 8.3689亿美元
预测年份 2032 1,420,270,000 美元
复合年增长率 (%) 9.03%

为了阐明影响多用途引流导管的设计、应用和性能预期的重要临床和技术要务。

多用途引流导管在现代介入医学中发挥核心作用，涵盖多个临床专科，可在各种临床环境下实现持续引流、标靶治疗和诊断性取样。材料科学、器械设计和手术技术的进步不断拓展这些器械的临床效用，同时也提高了人们对其安全性、耐用性和病患舒适度的期望。同时，强调门诊手术和日间管理的医疗模式的转变，也拓展了引流导管的应用范围，并影响临床医师的选择和采购重点。

识别能够重新定义引流导管解决方案产品开发和采购路径的临床、材料和商业性变更。

可重复使用引流导管的市场格局正受到多项变革性变化的影响，这些变化共同作用，影响着临床实践、采购行为和产品开发重点。首先，聚氨酯、硅胶和特氟龙等材料的创新提高了生物相容性并减少了污染，促使临床医生根据长期性能特征重新评估器械的选择。同时，管腔结构的进步，包括单腔、双腔和三腔结构，正在扩展器械的功能，以便在一次手术中满足复杂的引流和治疗需求。

评估2025年美国关税变化对引流导管製造商的设备采购、供应商策略和供应链韧性的实际影响

美国2025年关税政策的最新进展为医疗设备供应链的筹资策略、供应商选择和成本管理带来了新的考量。关税调整正在改变不同製造地的经济效益，促使企业重新评估离岸生产和本地生产之间的平衡。因此，采购团队和供应链经理更加重视供应商多元化，并寻找替代供应商以降低关税相关成本波动所带来的风险。

以细分市场主导的策略要务：将设备配置、临床应用、终端用户趋势、材料、尺寸和通路选择与商业成功联繫起来

从细分市场观点，我们可以发现产品类型、临床应用、终端用户环境、材料、器材尺寸和销售管道等方面存在着不同的机会和营运重点。这些因素会影响商业和研发策略。就产品类型而言，我们区分双腔、单腔和三腔三种配置，每种配置在功能、插入复杂性和维护要求方面各有优劣。心臟病学、胃肠病学、肾臟病学和泌尿系统等领域的广泛应用，对产品的性能、灭菌方法和临床医生培训提出了独特的要求。这些因素都应体现在有针对性的临床证据产生和标籤策略的发展中。

重点阐述了区域监管、临床和采购特征如何影响美洲、欧洲、中东和非洲以及亚太地区的产品策略。

区域趋势对监管要求、报销实际情况和临床实践规范有显着影响，导致产品开发和商业性化执行的优先事项有所不同。在美洲，尤其註重遵守集中式监管流程，以及医疗设备声明与支付方标准保持一致，这种环境通常鼓励产生严谨的临床证据并参与结构化的医院采购活动。同时，在欧洲、中东和非洲地区，不同的管理体制和采购行为往往需要根据当地情况制定监管策略、适应性标籤和灵活的分销方式，以满足各国的特定要求和临床实践。

差异化洞察阐述了专注于创新、卓越製造、临床伙伴关係和商业模式如何决定竞争优势。

多用途引流导管领域的企业发展趋势反映了创新领导、製造能力和商业性覆盖范围之间的平衡。主要企业透过投资尖端材料和涂层技术、运用监管专业知识确保广泛的标籤覆盖，以及与医疗系统合作获取真实世界证据，脱颖而出。与学术机构和专家进行策略合作，透过展示手术效率和以患者为中心的疗效，提升产品信誉度并加速临床应用。

实际可行、优先排序的策略行动，协调产品设计、供应链韧性、临床证据和商业管道，以加速产品推广应用并降低风险。

透过一系列优先且切实可行的步骤，产业领导者可以加速产品推广并保持成长，同时克服当前临床、监管和商业性的挑战。首先，将产品开发与临床医生的工作流程需求和材料性能目标相结合，可以确保设计变更能够带来可衡量的可用性和患者疗效提升。这需要在开发过程中持续收集临床医生的意见，并进行有针对性的上市后研究，以检验产品在实际应用中的表现。

对多资讯来源调查方法、证据三角验证和检验程序进行透明描述，以得出对相关人员可操作的见解。

本研究结合了对临床医生、采购负责人和行业高管的访谈，并辅以对监管指南、临床文献和供应链数据的二次分析，以确保研究结果的可靠三角验证。主要研究包括与心臟病学、胃肠病学、肾臟病学和泌尿系统的介入医师，以及来自医院、门诊手术中心、诊所和专科医疗中心的采购和供应链负责人进行结构化咨询。这些访谈揭示了医疗设备在实际应用中的性能优先事项、采购理由和服务期望。

综合分析将器械创新、不断发展的临床实践、供应链韧性和商业化联繫起来的策略意义，以推动相关人员采取决定性行动。

总而言之，材料技术的进步、诊疗流程向门诊转移以及不断变化的供应链压力，正在共同重塑引流导管领域製造商和相关人员的优先事项。器械设计人员必须平衡导管的柔软性、抗污染性和管腔设计，以满足不同的临床需求；而营运经理则必须预测受关税波动和区域监管复杂性影响的采购趋势。因此，商业性成功取决于能否将临床证据、供应弹性和针对医院、门诊中心、诊所和专科诊所特定需求量身定制的分销策略相结合。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 医用多用途引流导管市场（依产品类型划分）

  • 双腔
  • 单腔
  • 三流明

9. 医用多用途引流导管市场（依材料分类）

  • 聚氨酯
  • 硅酮
  • 铁氟龙

第十章 医用多用途引流导管市场（依尺寸划分）

  • 11-14 Fr
  • 5-7 Fr
  • 8-10 Fr
  • 14 法郎或以上

第十一章 医用多用途引流导管市场（依应用领域划分）

  • 心臟病学
  • 胃肠病学
  • 肾臟病学
  • 泌尿系统

第十二章 依最终用户分類的医用多用途引流导管市场

  • 门诊手术中心
  • 诊所
  • 医院
  • 专业中心

第十三章 医用多用途引流导管市场（依销售管道划分）

  • 直销
  • 批发的
  • 线上销售

第十四章 各地区医用多用途引流导管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 医用多用途引流导管市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国医用多用途引流导管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医用多用途引流导管市场

第十八章：中国医用多用途引流导管市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Convatec Group Plc
  • Cook Medical LLC
  • Johnson & Johnson
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-AE420CB13A89

The Medical Multi-Use Drainage Catheters Market was valued at USD 775.27 million in 2025 and is projected to grow to USD 836.89 million in 2026, with a CAGR of 9.03%, reaching USD 1,420.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 775.27 million
Estimated Year [2026] USD 836.89 million
Forecast Year [2032] USD 1,420.27 million
CAGR (%) 9.03%

Contextualizing the critical clinical and technological imperatives that shape the design, adoption, and performance expectations for multi-use drainage catheters

Multi-use drainage catheters occupy a central role in contemporary interventional practice across several clinical specialties, enabling continuous drainage, targeted therapies, and diagnostic sampling within diverse care settings. Advances in materials science, device design, and procedural techniques have extended the clinical utility of these devices while elevating expectations around safety, longevity, and patient comfort. In parallel, shifting care models that emphasize outpatient procedures and ambulatory management have broadened the contexts in which drainage catheters are deployed, influencing clinician preferences and procurement priorities.

Clinical stakeholders increasingly demand devices that balance ease of insertion and maintenance with infection control and biocompatibility. This has driven incremental innovation in device geometry, surface treatments, and lumen architecture to optimize flow dynamics and reduce occlusion risk. At the same time, regulatory scrutiny and reimbursement frameworks are shaping product development decisions, requiring manufacturers to demonstrate clear clinical benefit and cost-consequence advantages. As a result, research and development leaders are prioritizing cross-disciplinary collaboration among clinicians, material scientists, and engineers to align next-generation designs with procedural workflows and patient-centered outcomes.

Taken together, these factors are creating a dynamic environment in which technological capability, clinical evidence, and operational practicality must converge. Translating these convergent forces into commercially viable products requires an integrated approach that anticipates clinician needs, addresses supply chain resilience, and accommodates evolving regulatory expectations.

Identifying transformative clinical, material, and commercial shifts that are redefining product development and procurement pathways for drainage catheter solutions

The landscape for multi-use drainage catheters is being reshaped by several transformative shifts that collectively influence clinical practice, procurement behavior, and product development priorities. First, material innovations focusing on polyurethane, silicone, and Teflon variants are enabling improved biocompatibility and reduced encrustation, which in turn are prompting clinicians to reassess device selection based on long-term performance attributes. Concurrently, advances in lumen architecture, including single lumen, double lumen, and triple lumen configurations, are expanding device functionality to meet complex drainage and therapeutic needs within a single intervention.

Second, the migration of procedures toward ambulatory surgery centers and outpatient specialty centers is changing demand patterns and driving an emphasis on devices that facilitate rapid turnover, simplified maintenance, and minimized infection risk. In addition, digital health and remote monitoring solutions are beginning to interface with drainage systems to provide early warning for occlusion or infection, setting the stage for smarter device ecosystems. Third, procurement discipline and supplier consolidation among hospital systems are increasing expectations around supply chain transparency, total cost of ownership, and device training support.

Together, these shifts are encouraging manufacturers to pursue modular product lines, invest in clinical evidence generation across cardiology, gastroenterology, nephrology, and urology applications, and develop commercial models that align with evolving care delivery and reimbursement frameworks.

Assessing the practical implications of 2025 United States tariff changes on device sourcing, supplier strategies, and supply chain resilience for drainage catheter manufacturers

Recent tariff developments in the United States during 2025 have introduced new considerations for sourcing strategies, supplier selection, and cost management across the medical device supply chain. Tariff adjustments are altering the comparative economics of manufacturing locations and have prompted firms to reassess the balance between offshore production and regional manufacturing options. As a result, procurement teams and supply chain leaders are placing greater emphasis on supply base diversification and qualification of alternate suppliers to mitigate exposure to tariff-related cost volatility.

In addition, regulatory compliance and customs classification nuances are drawing increased attention, particularly for components such as specialized polymers, coatings, and connector assemblies used in multi-use drainage catheters. These inputs often cross multiple tariff lines, and changes in duty rates can influence decisions around component sourcing, in-house manufacturing versus outsourcing, and inventory strategies. Consequently, manufacturers are evaluating nearshoring or dual-sourcing approaches to reduce lead-time risk and to retain flexibility in response to policy shifts.

Moreover, tariff-driven cost pressures are accelerating conversations about value engineering and design optimization to maintain competitive pricing without compromising clinical performance. This includes exploring material substitutions, streamlined bill-of-materials, and process improvements in assembly. Collectively, tariff dynamics in 2025 are catalyzing more strategic supply chain design, putting a premium on contractual resilience and scenario planning that aligns procurement, regulatory, and commercial teams.

Segment-driven strategic imperatives that link device configurations, clinical applications, end-user dynamics, materials, sizing and channel choices to commercialization success

A segmentation-focused lens reveals differentiated opportunities and operational priorities across product types, clinical uses, end-user settings, materials, device sizes, and sales channels that shape commercial and development strategies. Product type considerations distinguish between double lumen, single lumen, and triple lumen configurations, each offering different clinical trade-offs in terms of functionality, insertion complexity, and maintenance needs. Application variability across cardiology, gastroenterology, nephrology, and urology introduces distinct performance requirements, sterilization practices, and clinician training imperatives, which should inform targeted clinical evidence generation and labeling strategies.

End user dynamics span ambulatory surgery centers, clinics, hospitals, and specialty centers, with each setting placing unique demands on device robustness, supply chain cadence, and post-procedural support. Material selection-whether polyurethane, silicone, or Teflon-affects device flexibility, encrustation resistance, and compatibility with adjunct therapies, and should be aligned to the clinical context and expected dwell times. Size differentiation across 11-14 Fr, 5-7 Fr, 8-10 Fr, and >14 Fr categories impacts insertion technique, drainage capacity, and patient comfort, necessitating clear sizing guidance and clinician education programs.

Finally, sales channel strategies that encompass direct sales, distributor networks, and online sales platforms each offer distinct advantages for market access, service-level agreements, and customer relationship management. Understanding how these segmentation dimensions interact will enable companies to prioritize product portfolios, tailor messaging to clinical stakeholders, and optimize distribution models for differential adoption across care settings.

Highlighting how distinct regional regulatory, clinical and procurement characteristics across the Americas, Europe Middle East & Africa and Asia-Pacific shape product strategy

Regional dynamics exert a strong influence on regulatory requirements, reimbursement realities, and clinical practice norms, creating differentiated priorities for product development and commercial execution. In the Americas, there is concentrated emphasis on compliance with centralized regulatory processes and the need to align device claims with payer criteria, an environment that frequently drives rigorous clinical evidence generation and structured hospital procurement engagements. Conversely, Europe, Middle East & Africa presents a mosaic of regulatory regimes and procurement behaviors, which often necessitates localized regulatory strategies, adaptable labeling, and flexible distribution approaches to address varied national requirements and clinical traditions.

Asia-Pacific demonstrates rapid adoption of innovative procedural approaches and a growing capacity for regional manufacturing and component sourcing. This region's heterogeneity in clinical practice, regulatory maturity, and supplier ecosystems creates both opportunities for scale and complexities in market entry. In each region, differences in hospital infrastructure, prevalence of ambulatory care models, and clinician training pathways will influence the prioritization of device features such as ease of maintenance, infection control enhancements, and clinician onboarding materials.

Therefore, a geographically nuanced approach is essential. Manufacturers must tailor regulatory dossiers, engagement plans with key clinical opinion leaders, and distribution strategies to account for regional variations in procurement cycles, reimbursement mechanisms, and procedural norms.

Corporate differentiation insights that outline how innovation focus, manufacturing excellence, clinical partnerships and commercial models determine competitive advantage

Company-level dynamics in the multi-use drainage catheter arena reflect a balance between innovation leadership, manufacturing capabilities, and commercial reach. Leading firms are differentiating through investments in advanced materials and coating technologies, regulatory expertise to secure broad labeling, and partnerships with healthcare systems to generate real-world evidence. Strategic collaborations with academic centers and specialty clinicians are enhancing product credibility and accelerating clinical adoption by demonstrating procedural efficiencies and patient-centered outcomes.

Operational excellence in manufacturing and supply chain management is a differentiator for companies seeking to maintain reliability in the face of tariff and logistics headwinds. Firms investing in validated supplier networks, quality management systems, and scalable assembly capacity are better positioned to meet stringent hospital procurement requirements. Additionally, companies that integrate strong customer support-through training programs, clinical education, and post-sale technical services-are more effective at sustaining long-term adoption and reducing device-related complications.

Finally, competitive positioning is affected by commercial model choices; those combining direct sales forces for complex accounts with distributor partnerships and selective online channels can optimize reach across hospitals, specialty centers, clinics, and ambulatory surgery centers. A focused approach to clinical evidence generation, coupled with robust supply chain resilience and tailored commercial models, tends to distinguish companies that achieve durable clinical and commercial traction.

Practical and prioritized strategic actions that align product design, supply resilience, clinical evidence and commercial channels to drive adoption and reduce risk

Industry leaders can adopt a set of prioritized, actionable measures to navigate current clinical, regulatory, and commercial challenges while accelerating adoption and sustaining growth. First, aligning product development with clinician workflow requirements and materials performance objectives will ensure that design changes translate into measurable improvements in usability and patient outcomes. This requires iterative clinician input during development and targeted post-market surveillance to validate real-world performance.

Second, strengthening supply chain resilience through diversified sourcing, dual-sourcing of critical components, and selective nearshoring options will reduce exposure to tariff-driven cost shifts and logistical disruption. Third, investing in tailored clinical evidence programs across cardiology, gastroenterology, nephrology, and urology will strengthen value propositions for payers and procurement teams, particularly when those studies demonstrate reductions in procedural complications or downstream resource use. Fourth, optimize commercial coverage by blending direct sales for complex institutional accounts with distributor and digital channels to reach clinics and ambulatory centers efficiently.

Finally, prioritize training and service bundles that reduce device-related complications and improve clinician satisfaction. By coordinating R&D, supply chain, clinical affairs, and commercial teams around these actions, organizations can create repeatable playbooks for product introduction and scale in diverse care settings.

Transparent description of the multi-source research methodology, evidence triangulation, and validation steps used to derive actionable insights for stakeholders

This study synthesizes primary interviews with clinicians, procurement professionals, and industry executives, augmented by secondary analysis of regulatory guidance, clinical literature, and supply chain data to ensure robust triangulation of findings. Primary research encompassed structured consultations with interventional specialists across cardiology, gastroenterology, nephrology, and urology, as well as procurement and supply chain leaders from hospitals, ambulatory surgery centers, clinics, and specialty centers. These conversations were employed to surface real-world device performance priorities, purchasing rationales, and service expectations.

Secondary research involved a systematic review of peer-reviewed clinical studies, regulatory documentation, and materials science literature relating to polyurethane, silicone, and Teflon device performance and biocompatibility. In addition, supply chain and tariff analyses were informed by customs classification documentation and public policy releases to contextualize procurement implications. Findings from primary and secondary sources were cross-validated through iterative analyst review and expert panel consultation to mitigate bias and to confirm practical relevance.

Where gaps in published evidence existed, targeted case reviews and device-level performance summaries were used to inform practical implications. The methodology emphasizes transparency, reproducibility, and a clear line of sight between source evidence and strategic recommendations.

Synthesis of strategic implications that connect device innovation, clinical practice evolution, supply resilience and commercialization for decisive stakeholder action

In synthesis, the confluence of material advancement, procedural migration to outpatient settings, and evolving supply chain pressures is reshaping priorities for manufacturers and clinical stakeholders in the drainage catheter domain. Device designers must balance flexibility, resistance to encrustation, and lumen design to meet diverse clinical needs while operational leaders must anticipate procurement dynamics driven by tariff shifts and regional regulatory complexity. Commercial success will therefore depend on the ability to align clinical evidence, supply resilience, and tailored distribution approaches to the specific demands of hospitals, ambulatory centers, clinics, and specialty units.

Clinicians and procurement professionals stand to benefit when manufacturers produce clear comparative evidence on device performance across the relevant sizes and lumen configurations and provide robust training and service support to reduce complications and optimize outcomes. Manufacturers that integrate regional regulatory strategies and flexible production footprints will be better positioned to respond to shifting trade policy and to local clinical preferences. Ultimately, the effective translation of technical innovation into clinical and commercial value requires coordinated cross-functional execution, ongoing engagement with clinical users, and disciplined scenario planning to navigate policy and supply uncertainties.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Multi-Use Drainage Catheters Market, by Product Type

  • 8.1. Double Lumen
  • 8.2. Single Lumen
  • 8.3. Triple Lumen

9. Medical Multi-Use Drainage Catheters Market, by Material

  • 9.1. Polyurethane
  • 9.2. Silicone
  • 9.3. Teflon

10. Medical Multi-Use Drainage Catheters Market, by Size

  • 10.1. 11-14 Fr
  • 10.2. 5-7 Fr
  • 10.3. 8-10 Fr
  • 10.4. >14 Fr

11. Medical Multi-Use Drainage Catheters Market, by Application

  • 11.1. Cardiology
  • 11.2. Gastroenterology
  • 11.3. Nephrology
  • 11.4. Urology

12. Medical Multi-Use Drainage Catheters Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Clinics
  • 12.3. Hospitals
  • 12.4. Specialty Centers

13. Medical Multi-Use Drainage Catheters Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales
  • 13.3. Online Sales

14. Medical Multi-Use Drainage Catheters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Multi-Use Drainage Catheters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Multi-Use Drainage Catheters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Multi-Use Drainage Catheters Market

18. China Medical Multi-Use Drainage Catheters Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AngioDynamics, Inc.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. Convatec Group Plc
  • 19.10. Cook Medical LLC
  • 19.11. Johnson & Johnson
  • 19.12. Medtronic plc
  • 19.13. Merit Medical Systems, Inc.
  • 19.14. Teleflex Incorporated
  • 19.15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DOUBLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TRIPLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY TEFLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 11-14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 5-7 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY 8-10 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY >14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY NEPHROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. GCC MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA MEDICAL MULTI-USE DRAINAGE CATHETERS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)